These data reveal a critical function of HDAC8 in the regulation of genome stability during chromatin replication, and the cancer-specific synthetic lethality by inhibiting HDAC8 and checkpoint kinases supports a promising strategy for replication stress–targeting cancer therapy. Here, HDAC8 is linked to cancer.